NCT06922357View on ClinicalTrials.gov

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Advanced/Metastatic Solid Tumors

Interventions

DRUG

HRS-6719

HRS-6719

Trial Locations (1)

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY